Children's Cancer Therapy Development Institute Press Releases - EIN Presswire

Published on September 30, 2024 - 23:01 GMT

Megan's Mission Foundation Awards $222,120 in Rhabdomyosarcoma Research Support

The Children's Cancer Therapy Development Institute has been awarded $222,120 by the Megan's Mission Foundation to advance three clinical research initiatives. HILLSBORO, OR, UNITED STATES, September 30, 2024 /⁨EINPresswire.com⁩/ -- The Children’s …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on August 17, 2024 - 17:54 GMT

Children’s Cancer Therapy Development Institute highlights potential of entinostat as a combinatorial therapy for cancer

Children’s Cancer Therapy Development Institute highlights potential of entinostat as a combinatorial therapy for rhabdomyosarcoma HILLSBORO, OR, UNITED STATES, August 17, 2024 /⁨EINPresswire.com⁩/ -- In a groundbreaking study published today in …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on July 14, 2024 - 02:26 GMT

Claire Newman appointed new Executive Director of Children’s Cancer Therapy Development Institute

Former Intel Executive, Claire Newman, takes post as the new Executive Director of the Children’s Cancer Therapy Development Institute. HILLSBORO, OREGON, UNITED STATES, July 13, 2024 /⁨EINPresswire.com⁩/ -- The Children’s Cancer Therapy Development …

Distribution channels: Business & Economy, Education ...

Published on April 2, 2024 - 09:00 GMT

Children's Cancer Therapy Development Institute collaborates globally with Atomwise using newly published AI technology

HILLSBORO, OREGON, UNITED STATES, April 2, 2024 /⁨EINPresswire.com⁩/ -- The Children’s Cancer Therapy Development Institute (cc-TDI), proudly announces a global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the …

Distribution channels: Science, Technology ...

Published on March 15, 2024 - 16:00 GMT

Children’s Cancer Therapy Development Institute Awarded $1M From State of Oregon for Cutting-Edge Research Equipment

HILLSBORO, OR, UNITED STATE, March 15, 2024 /⁨EINPresswire.com⁩/ -- In a significant stride towards advancing pediatric cancer research, the state of Oregon has allocated a generous $1 million grant to the Children’s Cancer Therapy Development Institute ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 6, 2024 - 18:00 GMT

Children’s Cancer Therapy Development Institute joins Cancer Grand Challenges team taking on solid tumors in children

HILLSBORO, OR, UNITED STATES, March 6, 2024 /⁨EINPresswire.com⁩/ -- The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2024 - 21:55 GMT

Megan's Mission Foundation Awards $100,000 in RMS Research Support

HILLSBORO, OREGON, UNITED STATES, January 9, 2024 /⁨EINPresswire.com⁩/ -- The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research studies for Rhabdomyosarcoma (RMS) by the Megan’s Mission Foundation. …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 06:45 GMT

Furthering Megan's Mission Through Rhabdomyosarcoma Research

Megan Bugg's legacy furthers Rhabdomyosarcoma research at the Children's Cancer Therapy Development Institute in hopes of better outcomes for children. HILLSBORO, OREGON, USA, October 3, 2023 /⁨EINPresswire.com⁩/ -- The Children’s Cancer Therapy …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 25, 2023 - 22:03 GMT

A Newly Published Study Suggests a Framework for Rhabdomyosarcoma Drug Development

This study canvased 640,000 potential drugs and drug-like compounds for RMS and Azelnidipine, a DHP drug, was chosen as the lead candidate for further testing. HILLSBORO, OR, UNITED STATES, May 25, 2023 /⁨EINPresswire.com⁩/ -- The scientific team at the …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 28, 2023 - 20:44 GMT

Announcing the Grand Opening of the Children’s Cancer Therapy Development Institute’s New Laboratory in Hillsboro, OR

cc-TDI's new Silicon Forest-based laboratory offers state-of-the-art facilities that allow for the expansion of preclinical research on rare childhood cancers. HILLSBORO, OREGON, UNITED STATES, April 28, 2023 /⁨EINPresswire.com⁩/ -- The Children’s …

Distribution channels: Companies, Education ...

Published on March 23, 2023 - 23:59 GMT

International Team addresses Rare Teenage and Young Adult Cancer in late-breaking publication

LANDMARK INTERNATIONAL COLLABORATION CREATES A FOUNDATION FOR DRUG DEVELOPMENT IN YOUNG ADULT CANCER CALLED CCS, OPENING THE DOOR TO NEW POTENTIAL THERAPY THE SILICON FOREST, HILLSBORO, OREGON, USA, March 23, 2023 /⁨EINPresswire.com⁩/ -- Researchers at …

Distribution channels: Science, Technology ...

Published on February 11, 2023 - 15:05 GMT

Megan's Mission Foundation Awards $100,000 in Rhabdomyosarcoma Research Funding

The Children’s Cancer Therapy Development Institute was awarded $100,000 for groundbreaking Rhabdomyosarcoma research by the Megan’s Mission Foundation. BEAVERTON, OREGON, UNITED STATES, February 11, 2023 /⁨EINPresswire.com⁩/ -- The Children’s Cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 9, 2023 - 18:37 GMT

The Lyla Nsouli Foundation Awards $100,000 in DIPG Research Funding

BEAVERTON, OREGON, UNITED STATES, January 9, 2023 /⁨EINPresswire.com⁩/ -- The Children’s Cancer Therapy Development Institute (cc-TDI) awarded $100,000 in support in support of Diffuse Intrinsic Pontine Glioma (DIPG) research by The Lyla Nsouli Foundation …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 14, 2022 - 18:44 GMT

World's First Pax7-Foxo1 Genetically Engineered Mouse Developed

Researchers have developed the first genetically-engineered mice containing the Pax7-Foxo1 gene fusion found in some forms of alveolar rhabdomyosarcoma. BEAVERTON, OR, UNITED STATES, November 14, 2022 /⁨EINPresswire.com⁩/ -- Children’s Cancer Therapy …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on July 19, 2022 - 17:37 GMT

Groundbreaking Epithelioid Sarcoma Study Reveals Clues to Treatment Discovery

BEAVERTON, OREGON, UNITED STATES, July 19, 2022 /⁨EINPresswire.com⁩/ -- Children’s Cancer Therapy Development Institute (cc-TDI) Biomedical Engineer Samuel Rasmussen led a study with global collaboration published in the journal, Clinical and Translational …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...